フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Enables Crescita to Participate in the Growing Medical Aesthetics Market Provides Commercial Platform for Crescita’s Medical and Aesthetic...
Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven Canadian commercial dermatology company...
- Continued Expansion of Pliaglis® Worldwide - Strong Cash Balance of $13.1 Million - Growth in Manufacturing Segment due to New Purchase...
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...
Positive Adjusted EBITDA1 and Strong Liquidity Position Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a...
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company, is pleased to...
F2020 Adjusted EBITDA1 of $3.2M Strong Ending Cash Position of $14.3M Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or...
Crescita Announces Filing of New Medical Device License PR Newswire LAVAL, QC, Jan. 21, 2021 Laboratoires...
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid PR Newswire LAVAL, QC, Nov. 26, 2020...
Crescita Reports Third Quarter 2020 Results PR Newswire LAVAL, QC, Nov. 12, 2020 Strong Ending Cash Balance of...
Crescita Announces Licensing Agreement for Pliaglis® in China PR Newswire LAVAL, QC, Nov. 5, 2020...
Crescita Reports Second Quarter 2020 Results PR Newswire LAVAL, QC, Aug. 12, 2020 Strong Ending Cash Balance of $9.3M LAVAL, QC, Aug. 12, 2020...
Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement PR Newswire LAVAL, QC, July 28, 2020...
Crescita Reports First Quarter 2020 Results PR Newswire LAVAL, QC, May 27, 2020 Positive Adjusted EBITDA1 and...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す